Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rama Al Hamed

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bone Marrow Transplantation|May 16, 2019
Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalitiesRama Al Hamed, Abdul Hamid Bazarbachi, Mohamad Mohty
Therapeutic Advances in Hematology|November 9, 2019
Allogeneic transplant for <i>FLT3</i>-<i>ITD</i> mutated AML: a focus on <i>FLT3</i> inhibitors before, during, and after transplantAbdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, et al.
Blood Cancer Journal|April 10, 2019
Current status of autologous stem cell transplantation for multiple myelomaRama Al Hamed, Abdul Hamid Bazarbachi, Florent Malard, et al.
Leukemia|August 29, 2019
Relapsed refractory multiple myeloma: a comprehensive overviewAbdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, et al.
Journal of Hematology & Oncology|August 31, 2022
Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk diseaseRazan Mohty, Rama Al Hamed, Ali Bazarbachi, et al.
Blood Cancer Journal|March 29, 2022
Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an updateAbdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, et al.
Blood Cancer Journal|May 19, 2021
Comprehensive Review of AL amyloidosis: some practical recommendationsRama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, et al.
Blood Cancer Journal|July 10, 2021
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapiesRazan Mohty, Rémy Dulery, Abdul Hamid Bazarbachi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 18, 2021
Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxisKaiwen Chen, Esther Arbona-Haddad, Matthew P Cheng, et al.
Bone Marrow Transplantation|September 29, 2019
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bone Marrow Transplantation|May 16, 2019
Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalitiesRama Al Hamed, Abdul Hamid Bazarbachi, Mohamad Mohty
Therapeutic Advances in Hematology|November 9, 2019
Allogeneic transplant for <i>FLT3</i>-<i>ITD</i> mutated AML: a focus on <i>FLT3</i> inhibitors before, during, and after transplantAbdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, et al.
Blood Cancer Journal|April 10, 2019
Current status of autologous stem cell transplantation for multiple myelomaRama Al Hamed, Abdul Hamid Bazarbachi, Florent Malard, et al.
Leukemia|August 29, 2019
Relapsed refractory multiple myeloma: a comprehensive overviewAbdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, et al.
Journal of Hematology & Oncology|August 31, 2022
Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk diseaseRazan Mohty, Rama Al Hamed, Ali Bazarbachi, et al.
Blood Cancer Journal|March 29, 2022
Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an updateAbdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, et al.
Blood Cancer Journal|May 19, 2021
Comprehensive Review of AL amyloidosis: some practical recommendationsRama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, et al.
Blood Cancer Journal|July 10, 2021
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapiesRazan Mohty, Rémy Dulery, Abdul Hamid Bazarbachi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 18, 2021
Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxisKaiwen Chen, Esther Arbona-Haddad, Matthew P Cheng, et al.
Bone Marrow Transplantation|September 29, 2019
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
Pageof 2